Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
167 The New Diabetes Drug Canagliflozin Enhances...
Journal article

167 The New Diabetes Drug Canagliflozin Enhances the Response of Prostate Cancer to Radiotherapy

Authors

Mekhaeil B; Zacharidis P; Tsakiridis E; Biziotis O-D; Broadfield L; Menjolian G; Mathurin T; Farrell T; Muti P; Liu S

Journal

Radiotherapy and Oncology, Vol. 139, , pp. s71–s72

Publisher

Elsevier

Publication Date

10 2019

DOI

10.1016/s0167-8140(19)33223-2

ISSN

0167-8140